Kintor Pharma Included in MSCI China Index

SUZHOU, China, May 15, 2022 /PRNewswire/ — Kintor Pharmaceutical Limited (“Kintor Pharma,” HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced today that the company’s stock has been included in the MSCI China…

About the Author

has written 41611 stories on this site.

Copyright © 2010 Business and Corporate News.